Tesamorelin 5mg + Ipamorelin 5mg (10mg Blend)

£89.99

Research Studies:

  • Facilitates dual-pathway analysis of GHRH and ghrelin-mimetic somatotroph secretagogue signaling
  • Supports investigation into synergistic cAMP-dependent and calcium-mediated growth hormone release
  • Enables research on GH-mediated lipolysis and visceral adipose tissue metabolic flux
  • Useful for evaluating hypothalamic-pituitary-somatotropic axis regulation in cellular assay models

Blend Specification:

  • Tesamorelin 5mg
  • Ipamorelin 5mg
SKU: A-83461 Category: Tags: ,
Description

Tesamorelin 5mg + Ipamorelin 5mg (10mg Blend) is a research-use-only peptide blend supplied for controlled laboratory workflows, multi-compound documentation review, and analytical characterization. This blend is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

Key Product Details

  • Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
  • Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
  • Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
  • Produced with lot-level traceability to support research documentation and laboratory recordkeeping.
  • Formulated as a multi-compound research blend containing Tesamorelin 5mg and Ipamorelin 5mg.

Research Documentation Context

  • Supports review of multi-compound blend composition in controlled laboratory settings.
  • Provides batch-specific identity and purity documentation for research review.
  • Allows lot-level traceability across laboratory documentation workflows.
  • Supports comparison of product labeling, analytical documentation, and storage information during research planning.
  • Assists researchers in evaluating individual component amounts within a clearly disclosed peptide blend.

Specifications and Documentation

  • Blend Composition: Tesamorelin 5mg + Ipamorelin 5mg, 10mg total.
  • Certificate of Analysis: Available with batch-specific documentation where applicable.
  • Material Safety Data Sheet: Coming Soon.
  • Handling and Storage Instructions: Coming Soon.
  • Product Form: Lyophilized powder.
  • Purity Specification: ≥99% purity.
  • Intended Use: Laboratory research use only.

Tesamorelin 5mg + Ipamorelin 5mg (10mg Blend) is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.

Additional information
CAS No.

Ipamorelin: 170851-70-4 Tesamorelin: 218949-48-5

Molecular Formula

Ipamorelin: C38H49N9O5 Tesamorelin: C221H366N72O67S

Molecular Weight

Ipamorelin: 711.85 g/mol Tesamorelin: 5135.89 g/mol

Purity

≥99%

Sequence

Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2 Tesamorelin: GRF (1-44) analog: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Gln-Gly-Ala-Arg-Ala-Arg-Leu-NH2

Synthesis Method

Solid-phase synthesis

Format

Lyophilized powder

Solubility

Water/Sterile Diluent

Stability & Storage

Up to 24 months at -20°C. Avoid repeated freeze-thaw cycles.

Applications

GH modulation

,

body composition

,

aging research

,

neuroprotection

Appearance

White to off-white powder

Regulatory/Compliance

Not for human consumption. For research use only.

Safety Information

MSDS available upon request

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.